JP2022512941A5 - - Google Patents

Info

Publication number
JP2022512941A5
JP2022512941A5 JP2021524356A JP2021524356A JP2022512941A5 JP 2022512941 A5 JP2022512941 A5 JP 2022512941A5 JP 2021524356 A JP2021524356 A JP 2021524356A JP 2021524356 A JP2021524356 A JP 2021524356A JP 2022512941 A5 JP2022512941 A5 JP 2022512941A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
cationic amphiphilic
amphiphilic polymer
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021524356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512941A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060807 external-priority patent/WO2020097614A2/en
Publication of JP2022512941A publication Critical patent/JP2022512941A/ja
Publication of JP2022512941A5 publication Critical patent/JP2022512941A5/ja
Pending legal-status Critical Current

Links

JP2021524356A 2018-11-09 2019-11-11 核酸送達のためのハイブリッド犠牲細胞透過性複合体 Pending JP2022512941A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862758487P 2018-11-09 2018-11-09
US62/758,487 2018-11-09
PCT/US2019/060807 WO2020097614A2 (en) 2018-11-09 2019-11-11 Hybrid immolative cell-penetrating complexes for nucleic acid delivery

Publications (2)

Publication Number Publication Date
JP2022512941A JP2022512941A (ja) 2022-02-07
JP2022512941A5 true JP2022512941A5 (cg-RX-API-DMAC7.html) 2022-11-17

Family

ID=70612292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524356A Pending JP2022512941A (ja) 2018-11-09 2019-11-11 核酸送達のためのハイブリッド犠牲細胞透過性複合体

Country Status (9)

Country Link
US (1) US12215341B2 (cg-RX-API-DMAC7.html)
EP (1) EP3877002A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022512941A (cg-RX-API-DMAC7.html)
KR (1) KR20210125979A (cg-RX-API-DMAC7.html)
CN (1) CN113573740A (cg-RX-API-DMAC7.html)
AU (1) AU2019377137B2 (cg-RX-API-DMAC7.html)
CA (1) CA3119288A1 (cg-RX-API-DMAC7.html)
IL (1) IL283037A (cg-RX-API-DMAC7.html)
WO (1) WO2020097614A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116724118A (zh) * 2020-07-24 2023-09-08 利兰斯坦福初级大学董事会 Covid-19的三组分疫苗
US20250177559A1 (en) 2022-03-09 2025-06-05 The Board Of Trustees Of The Leland Stanford Junior University Branched lipid charge-altering releasable transporters for nucleic acid delivery
EP4593884A1 (en) 2022-09-29 2025-08-06 The Board Of Trustees Of The Leland Stanford Junior University C-myc-targeting charge-altering releasable transporters as anti-tumor agents for breast cancer therapy
US20260191971A1 (en) 2022-11-08 2026-07-09 The Board Of Trustees Of The Leland Stanford Junior University Charge-altering nucleic acid transporters with beta-amido carbonate backbones
WO2025034780A1 (en) * 2023-08-08 2025-02-13 The Board Of Trustees Of The Leland Stanford Junior University Statistical charge-altering releasable transporters for nucleic acid delivery
WO2025034782A1 (en) * 2023-08-08 2025-02-13 The Board Of Trustees Of The Leland Stanford Junior University Charge-altering releasable transporters from amino alcohol initiators
US20250302763A1 (en) * 2024-02-22 2025-10-02 Capstan Therapeutics, Inc. Immune engineering amplification
WO2026026972A1 (zh) * 2024-08-01 2026-02-05 苏州百递博远生物科技有限公司 核酸递送载体及其制备与应用
WO2026026974A1 (zh) * 2024-08-01 2026-02-05 苏州百递博远生物科技有限公司 功能性聚碳酸酯及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
JP2004535388A (ja) 2001-04-30 2004-11-25 ターゲティッド ジェネティクス コーポレイション 脂質含有薬物送達複合体およびそれらの生成方法
WO2003106636A2 (en) * 2002-06-14 2003-12-24 Mirus Corporation Novel methods for the delivery of polynucleotides to cells
WO2013036532A1 (en) 2011-09-06 2013-03-14 The Board Of Trustees Of The Leland Stanford Junior University Amphipathic co-oligomers for the delivery of sirna
US20150329640A1 (en) * 2012-12-20 2015-11-19 Bluebird Bio, Inc. Chimeric antigen receptors and immune cells targeting b cell malignancies
BR112017020750A2 (en) 2015-03-27 2018-06-26 President And Fellows Of Harvard College modified t-cells and methods of producing and using them
US10654875B2 (en) 2015-11-12 2020-05-19 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
JP7179715B2 (ja) 2016-07-27 2022-11-29 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 核酸送達用の崩壊性細胞透過性複合体

Similar Documents

Publication Publication Date Title
Patel et al. Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium
Lee et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Hamilton et al. High-throughput in vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route
JP5906327B2 (ja) 磁性ナノ粒子−SAMiRNA複合体およびその製造方法
JP2023511271A (ja) 核酸搭載細胞外小胞
CN109054377B (zh) 一种树枝状聚酰胺胺结合氧化石墨烯复合材料及制备方法与应用
KR20120136345A (ko) 주형화된 나노컨쥬게이트
CN102449152A (zh) 双链核糖核酸的聚离子复合物
KR20170078843A (ko) 구형 핵산 나노입자 접합체의 서열 특이적 세포 흡수
CN102971002A (zh) 核酸递送用组合物及载体组合物、使用其的药物组合物以及核酸递送方法
BR112014014730B1 (pt) estrutura de droga polímero terapêutica, métodos para preparar uma estrutura de oligo rna de dupla hélice, nanoparticula e composição farmacêutica
AU2022201755B2 (en) Pharmaceutical composition for preventing or treating liver cancer
US11564884B2 (en) Cationic block polymer micelles for delivery of biological agents
US20160159834A1 (en) Alkyne phosphoramidites and preparation of spherical nucleic acid constructs
CN119074950A (zh) 一种增强mRNA-LNP组织靶向递送的方法
JPWO2021251453A5 (cg-RX-API-DMAC7.html)
Mullick Chowdhury et al. Graphene nanoribbon-based platform for highly efficacious nuclear gene delivery
Cao et al. Gene delivery by a cationic and thermosensitive nanogel promoted established tumor growth inhibition
JP2009527505A5 (cg-RX-API-DMAC7.html)
JP2025522366A (ja) 非ウイルス性送達組成物およびスクリーニング方法
CN105073141A (zh) 用于将基因递送到细胞的功能化dna树状聚合物
WO2024140546A1 (zh) 一种阳离子脂质化合物及制备方法和应用、mRNA递送系统
Zhao et al. Mass-ratio-controlled organ-selective phosphatidyl polymer carrier for in vivo targeted mRNA delivery
Zhang et al. A nanogel with passive targeting function and adjustable polyplex surface properties for efficient anti-tumor gene therapy
DE69802102T2 (de) Formulierung von stabilisierter kationischen transfektionsmittel/nukleinsäuren partikeln